e-learning
resources
Madrid 2019
Monday, 30.09.2019
It takes two to tango: translating scientific findings into clinical applications
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inflammatory cells and airway remodelling in COPD: clinical implications
M. Contoli (Ferrara (FE), Italy)
Source:
International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications
Session:
It takes two to tango: translating scientific findings into clinical applications
Session type:
Symposium
Number:
1878
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Contoli (Ferrara (FE), Italy). Inflammatory cells and airway remodelling in COPD: clinical implications. International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Inflammatory cells and airway remodelling in COPD
Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications
Year: 2019
Bronchial wall inflammatory cells and signs of remodeling in COPD and asthma
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
Clinical relevance of airway remodelling in airway diseases
Source: Eur Respir J 2007; 30: 134-155
Year: 2007
Inflammatory cell microlocalisation and airway dysfunction: cause and effect?
Source: Eur Respir J 2007; 30: 1043-1056
Year: 2007
Novel concepts in airway inflammation and remodelling in asthma
Source: Eur Respir J 2015; 46: 1796-1804
Year: 2015
Clinical and inflammatory determinants of (the course of) bronchial hyperresponsiveness in COPD
Source: Annual Congress 2010 - Lung morbidity on exposure to various agents
Year: 2010
Mast cells in COPD airways: relationship to bronchodilator responsiveness and angiogenesis
Source: Eur Respir J 2012; 39: 1361-1367
Year: 2012
Airway remodelling in asthma is related to particular characteristics of airway inflammation
Source: Eur Respir J 2002; 20: Suppl. 38, 188s
Year: 2002
Relationships between lung physiology and airway and systemic inflammation: a cohort study in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006
Airway epithelial inflammatory responses and clinical parameters in COPD
Source: Eur Respir J 2003; 22: 94-99
Year: 2003
Remodelling in paediatric respiratory disease and impact on growth and development
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=41
Year: 2006
Tools used to measure airway remodelling in research
Source: Eur Respir J 2007; 29: 596-604
Year: 2007
Alterations of the soluble proteome of airway epithelial cells in COPD
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
The EvA-Study: Markers of emphysema versus airway disease in COPD
Source: Annual Congress 2009 - EU Research Programmes: 1.GABRIEL 2.EvA 3.COPACETIC
Year: 2009
The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Airway inflammatory mediators and airway wall remodelling in asthma
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009
Disease specific effects of adrenomedullin in COPD and asthma derived human bronchial epithelial cells
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
Inflammatory cell phenotypes in bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 484s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept